Entry |
|
Name |
Navacaprant (USAN/INN) |
Formula |
C25H32FN5O2
|
Exact mass |
453.254
|
Mol weight |
453.5523
|
Structure |
|
Class |
Analgesic
DG01586 Opioid receptor antagonist
|
Remark |
|
Efficacy |
Antidepressant, Opioid receptor antagonist |
Comment |
Treatment of major depressive disorder
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Drug groups [BR:br08330]
Analgesic
DG01586 Opioid receptor antagonist
DG03305 Navacaprant
D12869 Navacaprant
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRK1
D12869 Navacaprant (USAN/INN)
Drug groups [BR:br08330]
Analgesic
DG01586 Opioid receptor antagonist
DG03305 Navacaprant
|
LinkDB |
|
KCF data |
ATOM 33
1 C8x C 7.4900 -15.8200
2 C8y C 7.4900 -17.2200
3 C8x C 8.7024 -17.9200
4 C8y C 9.9149 -17.2200
5 C8y C 9.9149 -15.8200
6 C8y C 8.7024 -15.1200
7 C8y C 11.1273 -17.9200
8 C8y C 12.3397 -17.2200
9 C8y C 12.3397 -15.8200
10 N5x N 11.1273 -15.1200
11 X F 8.7024 -13.7202
12 C1a C 11.1273 -19.3200
13 C1b C 6.2776 -17.9200
14 C1a C 5.0821 -17.2296
15 N1y N 13.5373 -15.1285
16 C8y C 13.5373 -17.9115
17 C1x C 14.7256 -15.8145
18 C1x C 15.9380 -15.1145
19 C1y C 15.9380 -13.7145
20 C1x C 14.7497 -13.0285
21 C1x C 13.5373 -13.7285
22 N1b N 17.1644 -13.0063
23 C1y C 18.3719 -13.7033
24 C1x C 18.3724 -15.1196
25 C1x C 19.5851 -15.8192
26 O2x O 20.7973 -15.1188
27 C1x C 20.7968 -13.7025
28 C1x C 19.5841 -13.0029
29 N5x N 13.6842 -19.3091
30 C8y C 15.0587 -19.6013
31 N5x N 15.7614 -18.3843
32 O2x O 14.8211 -17.3400
33 C1a C 15.6262 -20.8759
BOND 37
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 6 11 1
13 7 12 1
14 2 13 1
15 13 14 1
16 9 15 1
17 8 16 1
18 15 17 1
19 17 18 1
20 18 19 1
21 19 20 1
22 20 21 1
23 15 21 1
24 19 22 1
25 22 23 1
26 23 24 1
27 24 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 23 28 1
32 16 29 2
33 29 30 1
34 30 31 2
35 31 32 1
36 16 32 1
37 30 33 1
|